Do Some Randomized Controlled Trials Stack the Deck?
Patients in the control arm of cancer drug trials who progress are frequently not crossed over to the proven active therapy, leading to suboptimal care and problematic science, critics say.
Medscape Medical News
source https://www.medscape.com/viewarticle/994863?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/994863?src=rss
Comments
Post a Comment